Pirfenidone Clinical Trials
6 recruitingDrug
Phase 24Phase 32Phase 11
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)250 enrolled1 locationNCT03109288
Recruiting
Phase 3
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Long COVID
Douglas D. Fraser348 enrolled9 locationsNCT06928272
Recruiting
Phase 2
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim20 enrolled3 locationsNCT06241560
Recruiting
Phase 2
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
Recurrent Acute Pancreatitis
University of Alabama at Birmingham60 enrolled2 locationsNCT06253117
Recruiting
Phase 3
Pirfenidone to Prevent Fibrosis in Ards.
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele130 enrolled17 locationsNCT05075161
Recruiting
Phase 2
Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
Lung Cancer
Hubei Cancer Hospital41 enrolled1 locationNCT05801133